NCT06119893

Brief Summary

The aim of this study is to evaluate the effectiveness of submucosal 8 mg (2 mL) dexamethasone on postoperative pain, swelling, chewing efficiency, trismus, healing, and discomfort after periodontal flap surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 12, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2022

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

November 1, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

9 months

First QC Date

November 1, 2023

Last Update Submit

November 6, 2023

Conditions

Keywords

paindexamethasonesurgical flaps

Outcome Measures

Primary Outcomes (3)

  • VAS

    Visual analogue scale (VAS) was assessed to monitor the degree of pain.VAS is a scale that rates pain severity from 0 to 10. (0 = no pain to 10 = severe pain),

    Every hour for the first 8 hours on the first day of the operation, and three times a day on the 2nd, 3rd, 4th and 7th days

  • NRS-101

    101-point numeric rate scale (NRS-101) was assessed to monitor the degree of pain. NRS-101 is a 101-point numerical ratio scale that rates pain severity from 0 to 100. (0 = no pain to 100 = severe pain),

    Every hour for the first 8 hours on the first day of the operation, and three times a day on the 2nd, 3rd, 4th and 7th days

  • Swelling

    Linear measurements were taken for swelling with a millimeter tape measure. Measurements were made between the angle of the mandible and the mentus, labial commissure, nasal ala, outer corner of the eye and tragus. The average of these five measurements was noted.

    Patients were evaluated for swelling on the preoperative, the1st, 2nd, and 7th days after the operation

Secondary Outcomes (6)

  • Trismus

    It was evaluated for trismus on the preoperative, the 1st, 2nd, and 7th days after the operation

  • Chewing efficiency

    It was evaluated for chewing efficiency on the 1st, 2nd, and 7th days after the operation

  • Healing of operation area

    It was evaluated for healing of operation area on the 1st, 2nd, and 7th days after the operation

  • Discomfort

    It was evaluated for discomfort on the 1st, 2nd, and 7th days after the operation

  • Analgesics consumed

    The number of analgesics used each day during the first 7 days was noted by the patient in the pain diary

  • +1 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Patient received an indication periodontal flap surgery. In this randomized controlled split mouth study, the patient underwents periodontal flap surgery in their mandibular. Following local anesthesia (2% lidocaine and 1:100,000 epinephrine), sulcular incisions were made. Vertical incision was not used in any operation. The mucoperiosteal flap was elevated until the buccal and lingual bone defects were adequately exposed. Defects were thoroughly debrided firstly by using periodontal curettes, and then cleaned by piezoelectric ultrasonic scaler to ensure all granulation tissues were thoroughly removed. Buccal and lingual flaps were closed primarily. In the control group, 2 mL 0.9% isotonic sodium chloride (saline) with 27-gauge single-type disposable syringes was applied to the buccal surface of flap after the operation

Drug: submucosal 2 mL 0.9% isotonic sodium chloride application

Test Group

ACTIVE COMPARATOR

Patient received an indication periodontal flap surgery. In this randomized controlled split mouth study, the patient underwents periodontal flap surgery in their mandibular. Following local anesthesia (2% lidocaine and 1:100,000 epinephrine), sulcular incisions were made. Vertical incision was not used in any operation. The mucoperiosteal flap was elevated until the buccal and lingual bone defects were adequately exposed. Defects were thoroughly debrided firstly by using periodontal curettes, and then cleaned by piezoelectric ultrasonic scaler to ensure all granulation tissues were thoroughly removed. Buccal and lingual flaps were closed primarily. In the test group, 8 mg (2 mL) submucosal dexamethasone with 27-gauge single-type disposable syringes was applied to the buccal surface of flap after the operation

Drug: submucosal 8 mg (2 mL) dexamethasone application

Interventions

The mucoperiosteal flap was applied. After operation, submucosal dexamethasone 8 mg (2 mL) was applied to the operation area as a test group.

Also known as: Periodontal flap surgery
Test Group

The mucoperiosteal flap was applied. After operation, 2 mL 0.9% isotonic sodium chloride was applied to the operation area as a control group

Also known as: Periodontal flap surgery
Control Group

Eligibility Criteria

Age19 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • pocket depth ≥5mm;
  • systemically healthy;
  • without drug allergy;
  • without any blood disease;
  • not using medication (anti-platelet, anticoagulant, immunosuppressant medication);
  • received no any periodontal surgery in the last 6 months;

You may not qualify if:

  • poor oral hygiene;
  • smoking;
  • any systemic disease that would affect the surgical operation;
  • problem with the kidneys or adrenal glands;
  • connective tissue disease or immunodeficiency;
  • breastfeeding period or pregnancy.
  • high dental anxiety

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yuzuncu Yil University

Van, 65080, Turkey (Türkiye)

Location

Related Publications (4)

  • Vieth MP, Deas DE, Archontia Palaiologou A, Diogenes A, Mader MJ, Mealey BL. Effect of intravenous dexamethasone on postoperative pain and swelling following periodontal flap surgery: A randomized controlled trial of patient-centered outcomes. J Periodontol. 2022 Feb;93(2):237-245. doi: 10.1002/JPER.21-0153. Epub 2021 Jun 3.

    PMID: 34021915BACKGROUND
  • Steffens JP, Santos FA, Pilatti GL. Postoperative periodontal pain prevention using two dexamethasone medication protocols: a double-blind, parallel-group, placebo-controlled randomized clinical trial. Am J Dent. 2011 Dec;24(6):354-6.

    PMID: 22263332BACKGROUND
  • Aksoy F, Ege B. The effect of pretreatment submucosal injections of tramadol and dexamethasone on post-endodontic pain in mandibular molar teeth with symptomatic irreversible pulpitis: a randomized controlled clinical trial. Int Endod J. 2020 Feb;53(2):176-185. doi: 10.1111/iej.13246. Epub 2019 Nov 28.

    PMID: 31702056BACKGROUND
  • Altindal D, Alsafadi A, Alshujaa B, Talmac AC, Ege B, Calisir M, Alpaslan NZ. Effect of submucosal dexamethasone on postoperative pain, swelling and trismus after periodontal surgery: a randomized clinical study. Clin Oral Investig. 2024 Dec 4;28(12):681. doi: 10.1007/s00784-024-06076-5.

MeSH Terms

Conditions

Periodontal PocketPainEdemaPatient SatisfactionPeriodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Dicle Altindal, DDS

    Yuzuncu Yil University

    PRINCIPAL INVESTIGATOR
  • Anas ALSAFADI, PhD

    Special dental clinic

    STUDY CHAIR
  • Basem ALSHUJAA, PhD

    Special dental clinic

    STUDY CHAIR
  • Ahmet Cemil Talmac, PhD

    Yuzuncu Yil University

    STUDY CHAIR
  • Bilal Ege, PhD

    Adiyaman University

    STUDY CHAIR
  • Metin Calisir, PhD

    Adiyaman University

    STUDY CHAIR
  • Nazli Zeynep Alpaslan, PhD

    Yuzuncu Yil University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS, Assistant Professor

Study Record Dates

First Submitted

November 1, 2023

First Posted

November 7, 2023

Study Start

August 12, 2021

Primary Completion

April 29, 2022

Study Completion

April 29, 2022

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations